Abstract
Background This study developed a deep learning model to predict improvement of left ventricular ejection fraction in patients with heart failure.
Methods An internal database comprising clinical, laboratory and echocardiographic features obtained from the First Affiliated Hospital of Harbin Medical University was used to construct and train the deep learning model.
Results A total of 422 cases were included in this study. 122 (28.9%) were patients with HFimpEF, 300 (71.0%) were patients with HFrEF. Multivariable analyses showed that smaller baseline left atrial anterior-posterior diameter (LAD) and left ventricular end-diastolic diameter (LVEDD), higher baseline interventricular septal thickness at diastole (IVSD) and levels of prealbumin were the independent clinical predictors of LVEF improvement. Deep learning model demonstrated an overall predict accuracy of 96% in the validation set and 89% in the training set.
Conclusions Independent predictors of LVEF improvement were smaller baseline LVEDD, LAD, higher baseline IVSD and baseline levels of prealbumin. Our deep learning model had shown acceptable performance in predicting improvement of left ventricular ejection fraction in patients with heart failure.
Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT06070506.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT06070506
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of Frist Affiliated Hospital of Harbin Medical University
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All authors have read and approved the submission of the manuscript, which has not been published and is not being considered for publication elsewhere in whole or part in any language.
